Human Observatory Study

Condition(s) studied

Investigational drug(s) / intervention(s)

Multi-Domain Ecological and Clinical Data Linkage: Linkage of individual multi-system clinical health measurements to continuously-ingested ecological data from public and private registries spanning environmental, social, genealogical, and population health domains at geographic resolutions from home address to global scale and beyond. The linked dataset feeds a continuously-updating causal inference engine generating life expectancy estimates, disease cluster detection, individual screening recommendations, and population health intelligence.

Study summary

The Human Observatory Study is a prospective observational and ecological surveillance study building a continuously-updating world model for human health, disease, and death at the individual and population level. Individual multi-system clinical data from enrolled participants are linked to a continuously-ingested ecological data infrastructure spanning environmental exposures, social determinants, genealogical and family history records, mortality data, and population health databases at geographic resolutions from home address to global scale and beyond. The resulting model generates individual screening recommendations informed by population-level causal estimates, and population-level causal forecasts anchored by present-timepoint individual clinical biology. This linkage creates a feedback architecture designed to improve both simultaneously.

Eligibility

Primary outcome measure(s)

• Life Expectancy Estimates by Geography — From enrollment until death, assessed periodically, up to 100 years
  Continuously-updated life expectancy point estimates with credible intervals generated at individual, neighborhood, ZIP code, county, state, national, global, and beyond-earth scales using individual clinical data linked to population mortality records, environmental context, and ecological data.
• Geographic Disease Cluster and Outbreak Detection — From enrollment until death, assessed periodically, up to 100 years
  Statistically anomalous concentrations of incident disease, mortality spikes, or shared symptom patterns at neighborhood and community resolution.

Trial sites (1)

More Longevity Metrics, Inc. trials in the USA

Other trials for the same condition